Adial Pharmaceuticals, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Adial Pharmaceuticals, Inc. (ADIL) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $506.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Notes › Fair Value Disclosures
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2023-05-12
- 2023-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $506.00K.
- 2022-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $492.00K.
- 2022-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $817.00K.
- 2022-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $892.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2023-03-31 | $506.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $492.00K 10-Q · filed 2023-05-12 |
| 2022-09-30 | $817.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $892.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $868.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.01M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.07M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $793.49K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $726.01K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |